Chang et al identified ENO1 as LC associated antigen using similar serological approach and showed that increasing expression of ENO1 is a prevailing phenomenon in patients with NSCLC and its expression status is tightly correlated with disease recurrence and survival [30]. The gene discussed is ENO1; the disease is non-small cell lung carcinoma.